Search results
New PET agent provides same-day imaging for clear cell renal cell carcinoma patients
Medical Xpress· 7 hours agoA novel investigational PET imaging agent can rapidly and accurately visualize lesions in clear cell renal cell cancer (ccRCC) patients ...
Massive study identifies new biomarkers for renal cancer subtypes, improving diagnosis...
Medical Xpress· 1 day agoThe findings lay the groundwork to identify therapeutic targets in non-clear-cell renal cell carcinomas. ...
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients - British...
Nature· 4 days agoTregs trafficking is controlled by CXCR4. In Renal Cell Carcinoma (RCC), the effect of the new CXCR4 antagonist, R54, was explored in ...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 6 days agoModerna detailed plans for its individual neoantigen cancer vaccine in a first-quarter earnings...
Fighting Cancer: A Basic Guide To Checkpoint Inhibitors
Forbes· 2 days agoThis article is part of an ongoing series on novel cancer advances, including immunotherapies such...
Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 2 days agoInvestors' focus will likely be on Iovance's (IOVA) progress with its ongoing commercial launch for...
Afinitor interactions: Other medications, alcohol, and more
Medical News Today· 5 days agoAfinitor has interactions with some other drugs and certain supplements. Before you start treatment...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 7 days agoDelhi, May 01, 2024 (GLOBE NEWSWIRE) -- Global CD70 Targeting Therapies Market Opportunity & Clinical Trials Insight 2024 Report Highlights: CD70 Targeting Therapies In Clinical Trials: > 20 TherapiesCD 70 Targeting Therapies Clinical Trials
Exelixis (NASDAQ:EXEL) Earns “Outperform” Rating from William Blair
ETF DAILY NEWS· 4 days agoWilliam Blair reaffirmed their outperform rating on shares of Exelixis (NASDAQ:EXEL – Free Report) in a report published on Wednesday, RTT News reports. Barclays lowered Exelixis from an overweight ...
Sutent Dosage: Form, Strengths, How to Take, and More
Healthline· 7 days agoSutent is a prescription drug used to treat certain types of cancer. Learn about the drug's dosages, form, strengths, how to take it, and more.